IBDEI0FE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7068,2)
 ;;=^340538
 ;;^UTILITY(U,$J,358.3,7069,0)
 ;;=516.36^^31^425^5
 ;;^UTILITY(U,$J,358.3,7069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7069,1,4,0)
 ;;=4^516.36
 ;;^UTILITY(U,$J,358.3,7069,1,5,0)
 ;;=5^Crypto Organiz Pneu
 ;;^UTILITY(U,$J,358.3,7069,2)
 ;;=^340539
 ;;^UTILITY(U,$J,358.3,7070,0)
 ;;=516.37^^31^425^6
 ;;^UTILITY(U,$J,358.3,7070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7070,1,4,0)
 ;;=4^516.37
 ;;^UTILITY(U,$J,358.3,7070,1,5,0)
 ;;=5^Desquamatv Inters Pneu
 ;;^UTILITY(U,$J,358.3,7070,2)
 ;;=^340540
 ;;^UTILITY(U,$J,358.3,7071,0)
 ;;=516.4^^31^425^13
 ;;^UTILITY(U,$J,358.3,7071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7071,1,4,0)
 ;;=4^516.4
 ;;^UTILITY(U,$J,358.3,7071,1,5,0)
 ;;=5^Lymphangioleiomyomatosis
 ;;^UTILITY(U,$J,358.3,7071,2)
 ;;=^340541
 ;;^UTILITY(U,$J,358.3,7072,0)
 ;;=516.5^^31^425^2
 ;;^UTILITY(U,$J,358.3,7072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7072,1,4,0)
 ;;=4^516.5
 ;;^UTILITY(U,$J,358.3,7072,1,5,0)
 ;;=5^Adlt Pul Langs Cell Hist
 ;;^UTILITY(U,$J,358.3,7072,2)
 ;;=^340542
 ;;^UTILITY(U,$J,358.3,7073,0)
 ;;=516.62^^31^425^16
 ;;^UTILITY(U,$J,358.3,7073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7073,1,4,0)
 ;;=4^516.62
 ;;^UTILITY(U,$J,358.3,7073,1,5,0)
 ;;=5^Pulm Inters Glycogen
 ;;^UTILITY(U,$J,358.3,7073,2)
 ;;=^340544
 ;;^UTILITY(U,$J,358.3,7074,0)
 ;;=516.63^^31^425^21
 ;;^UTILITY(U,$J,358.3,7074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7074,1,4,0)
 ;;=4^516.63
 ;;^UTILITY(U,$J,358.3,7074,1,5,0)
 ;;=5^Surfac Mutat Lung
 ;;^UTILITY(U,$J,358.3,7074,2)
 ;;=^340545
 ;;^UTILITY(U,$J,358.3,7075,0)
 ;;=573.5^^31^425^7
 ;;^UTILITY(U,$J,358.3,7075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7075,1,4,0)
 ;;=4^573.5
 ;;^UTILITY(U,$J,358.3,7075,1,5,0)
 ;;=5^Hepatopulm Syndrome
 ;;^UTILITY(U,$J,358.3,7075,2)
 ;;=^340555
 ;;^UTILITY(U,$J,358.3,7076,0)
 ;;=493.92^^31^426^1
 ;;^UTILITY(U,$J,358.3,7076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7076,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,7076,1,5,0)
 ;;=5^Asthma NOS w/Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,7076,2)
 ;;=^330092
 ;;^UTILITY(U,$J,358.3,7077,0)
 ;;=493.91^^31^426^2
 ;;^UTILITY(U,$J,358.3,7077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7077,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,7077,1,5,0)
 ;;=5^Asthma NOS w/Status Astmaticus
 ;;^UTILITY(U,$J,358.3,7077,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,7078,0)
 ;;=493.90^^31^426^3
 ;;^UTILITY(U,$J,358.3,7078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7078,1,4,0)
 ;;=4^493.90
 ;;^UTILITY(U,$J,358.3,7078,1,5,0)
 ;;=5^Asthma NOS w/o Exacerbation
 ;;^UTILITY(U,$J,358.3,7078,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,7079,0)
 ;;=466.19^^31^426^6
 ;;^UTILITY(U,$J,358.3,7079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7079,1,4,0)
 ;;=4^466.19
 ;;^UTILITY(U,$J,358.3,7079,1,5,0)
 ;;=5^Bronchiolitis,Acute
 ;;^UTILITY(U,$J,358.3,7079,2)
 ;;=^304310
 ;;^UTILITY(U,$J,358.3,7080,0)
 ;;=493.82^^31^426^15
 ;;^UTILITY(U,$J,358.3,7080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7080,1,4,0)
 ;;=4^493.82
 ;;^UTILITY(U,$J,358.3,7080,1,5,0)
 ;;=5^Cough Variant Asthma
 ;;^UTILITY(U,$J,358.3,7080,2)
 ;;=^329927
 ;;^UTILITY(U,$J,358.3,7081,0)
 ;;=493.81^^31^426^17
 ;;^UTILITY(U,$J,358.3,7081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7081,1,4,0)
 ;;=4^493.81
 ;;^UTILITY(U,$J,358.3,7081,1,5,0)
 ;;=5^Exercise Induced Bronch
 ;;^UTILITY(U,$J,358.3,7081,2)
 ;;=^329926
 ;;^UTILITY(U,$J,358.3,7082,0)
 ;;=494.1^^31^426^4
 ;;^UTILITY(U,$J,358.3,7082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7082,1,4,0)
 ;;=4^494.1
 ;;^UTILITY(U,$J,358.3,7082,1,5,0)
 ;;=5^Bronchiectasis w/Exacerbation
 ;;
 ;;$END ROU IBDEI0FE
